Bimal Malhotra
Biography
Pre-Clinical and Clinical Drug Development of New Chemical Entities
• Phase IV Clinical Development of Alternate Dosage Forms/Dosage Regimens and New Indications for Marketed Drug Products
• Phase I Clinical Pharmacology Studies
• Specialty PK, PK/PD, and Biopharmaceutics Studies
• Clinical Abuse Potential Studies
• Global Regulatory Interactions for Drug Product Development, Registration and Labeling
• Bioanalytical Method Development and Validation